Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia - Contacts and Locations

Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00333177

Contacts


Contact: Rosemary Collier, MA	310-206-5090	rcollier@mednet.ucla.edu

Contact: Luana Turner, PsyD	310-974-7340	luana@ucla.edu

Locations


United States, California
	Semel Institute for Neuroscience and Human Behavior at UCLA	Recruiting
	Los Angeles, California, United States, 90095
	Principal Investigator: Keith H. Nuechterlein, PhD
	Sub-Investigator: Kenneth L. Subotnik, PhD
	Sub-Investigator: Joseph Ventura, PhD
	Sub-Investigator: John Luo, MD

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

Investigators


Principal Investigator:	Keith H. Nuechterlein, PhD	University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences